Your leads aren't cold, they're in the Lead Nurture Gap

The hardest part of Life Science and Biotech marketing isn’t generating interest but staying relevant and visible across the 9 -24 months before your audience buys. That’s exactly where we support you. 

A 30 minute diagnostic conversation to identify where your nurture programmes are underperforming.

You already know what good looks like

A pipeline you can explain to the CEO. Leads that move from MQL (Marketing Qualified Lead) to SAL (Sales Accepted Lead) without a battle with sales. Marketing’s contribution to revenue is visible, defensible, and yours.

What’s missing isn’t effort or content volume, but a structured buyer progression system built for the reality of Life Science evaluation cycles; not 30-day campaign bursts.

That’s what Qincade builds.

Here is the reality most Life Science marketing leaders recognise but rarely say out loud

Leads enter your CRM after a campaign or event, full of potential. Then follow-up becomes sporadic, driven by internal timelines rather than where the buyer actually is in their evaluation. Engagement stalls and pipeline cools.

The external problem looks like strong campaign activity that doesn’t translate to pipeline movement.

But the real problem is that you’re being asked to show defensible ROI against a nurture model that was never designed for 9-24 month buying cycles with multi-stakeholder committees.

It’s not right that a Head of Marketing running technically credible campaigns, with a CRM full of qualified contacts, has to still spend time defending marketing’s contribution to revenue.

The Lead Nurture Gap – the unmanaged middle phase of the Life Science buyer’s journey – is the reason that gap exists. And it’s fixable.

The Lead Nurture Gap by Qincade

We understand what that position feels like

  • Being measured on MQL conversion.
  • Under pressure to show pipeline clarity.
  • Working with a Sales Team that won’t engage because the leads don’t feel ready – while you know the interest is real.


We have spent years inside this problem within Life Science, Biotech, and MedTech companies. Our own analysis shows the average time from first content engagement to closed deal can exceed 800 days, and generic nurture sequences modelled around SaaS timelines just don’t account for that.


We’ll build you a system that does.

What our customers say:

With just the first email, our sales reps have already booked several meetings and sold the first two items!

– Marketing Programmes Lead, MedDevices Instruments Company

We turned to Qincade to help drive our marketing initiatives forward. Together, we executed a seamless, multi-phase campaign with integrated lead nurturing workflows. Qincade’s team was fast, focused, and responsive, making the entire process both efficient and highly effective.

– Director, Demand Generation and Corporate Marketing, Lab Instruments Manufacturing Company

You all have done a fabulous job on this campaign; the sales scripts are great… we’re looking forward to reaping the fruit!

– Sr. Product Marketing Manager, Life Sciences Company

Is this for you?

You’ll likely benefit if your organisation matches this profile:

  • You use HubSpot, Salesforce, Marketo, or a similar CRM or MAP
  • You have a database of 1500 or more scientific or technical buyers
  • Your sales cycle runs to 9 months or longer
  • Sales says your leads aren’t warm enough
  • You’re generating engagement but not enough pipeline movement
  • You need to show measurable ROI, and you need to show it soon

If Sales is already complaining that your leads aren’t ready, that’s the Lead Nurture Gap, hiding in plain sight.

Here's how we approach things

Phase 1: Diagnose
Your free 30 minute Readiness Review identifies exactly where buyer progression is breaking down in your current system and benchmarks where you sit across our four-stage capability model. Going from lead generation only (level 1) to evaluation influence (level 4).

Phase 2: Build
We design and implement your lead progression system on top of your existing tech stack. Per product portfolio or per ICP. No new platforms are required, and there’s no need for additional headcount. Typically live within 5-6 weeks of starting to work together.

Phase 3: Progress
Leads start moving. Engagement signals become visible. Sales receives contacts with more context that are easier to follow up. You have a pipeline that you can explain and revenue that you can attribute to marketing motion.

Our commitment to you

If we don’t believe buyer progression is your real bottleneck, we’ll tell you that in the Readiness Review – directly, with no obligation and no pitch.

Find out where your pipeline is actually stalling

The Readiness Review is free, focused, and takes about 30 minutes. You will leave with a clear diagnostic of where your leads are losing momentum, and what a structured progression system would change.

One direct question

If your nurture model stays as it is – the same sporadic follow-up, the same conversation with Sales about lead readiness, the same quarterly review where marketing defends activity rather than demonstrating pipeline – what does that mean for your position in 12 months?

The contacts in your CRM right now are as engaged as they are going to be without structured progression. With every quarter without a system in place, that pipeline conversation becomes harder to achieve with confidence.

What changes when buyer progression works

Imagine how differently your next quarterly review can start. You open with showing pipeline movement, not engagement metrics. You show leads that progressed, conversations that started, and revenue that traces back to your marketing campaigns.

Sales is engaged because the contacts arriving in their queue are genuinely ready for commercial conversations. Leadership starts to see marketing as a critical commercial function, not a cost centre. And you are the person who has built the system that made it measurable.

For the marketing leaders we work with, it’s not a distant theory; it’s a real outcome.

The pipeline uplift you need is already in your database

You don’t need more leads. You need a progression system built for the way Life Science buyers actually make decisions.

Book your free Readiness Review; a focused 30 minute conversation to get a clearer picture of where your pipeline stands – and what it would take to move it. No sales pitch. No obligation.

Is the Lead Nurture Gap already costing you pipeline?

Four questions about what is happening in your organisation right now. No numbers needed and your result updates as you answer.

Answer the questions on the left to see your diagnostic.

Still weighing it up?

Isn’t this just what our marketing team should be doing already?

You may be thinking:

  • “We already have nurture emails.”
  • “Our agency helps with campaigns.”
  • “We should be able to do this in‑house.”


Most teams do have bits and pieces of this, but what’s missing is the end‑to‑end system that joins them up:

  • A shared definition of ICPs, stages and signals.
  • Data that is actually usable for segmentation and reporting.
  • A full journey from first touch through to sales‑ready, not just a few newsletters.
  • Sales tools that are built from the same narrative, not bolted on at the end.


This isn’t “a few emails stitched together”. It is a complete progression layer over your existing stack that removes guesswork and inconsistency from trying to prove movement of prospects towards MQLs and then SQL stage.

 

Your team stays focused on running the business, and our system gives them a proven process to monitor and report from with greater confidence. 

This methodology is designed to reduce ongoing strain, not increase it.

You will need:

  • Access to a CRM and some existing marketing content

  • One commercial sponsor to keep decisions moving

  • Structured input at key milestones

You will not need:

  • New tech

  • New headcount

  • Daily operational oversight

  • Frequent involvement from Sales

Most organisations see early engagement and progression signals within 30–60 days, with sales-ready conversations typically visible within 90 days.

The goal is not immediate volume, but measurable movement of the most promising and engaged leads towards commercially significant conversations. 

Yes. The work is front‑loaded on our side, with your team involved a few hours a month for decisions and approvals. The goal is to give you time back by reducing manual follow‑up and ad‑hoc firefighting.

Yes, because the system surfaces context and signals, not just lead scores.

Sales receives:

  • Insight into buyer engagement

  • Mapped progression stages

  • Defined “ready” triggers

  • Scripts, content assets, and additional commercial nurture cadence as part of the Sales Bridge.

The goal is fewer, better-timed conversations rather than more activity.

No. Our progression engine is designed to activate and move the scientific audience you already have, not to generate more top-of-funnel volume.

Most Life Science organisations don’t have a shortage of leads but they do struggle with consistently warming their dormant contacts; clarity over which leads are progressing and how quickly, and creating sales-ready conversations from resultant engagement.

No. Our system works within your existing CRM and automation platforms. It clarifies structure, segmentation, and progression and does not require changing your existing infrastructure.

That’s common and expected.

The first phase of the system focuses on segmentation, ICP clarity, and identifying viable dormant contacts (e.g. recent closed-lost opportunities, champions who moved to new companies, old MQLs or accounts that showed intent and then went quiet). Then we enrich the records, narrow to ICP-fit accounts, requalify the opportunities, and run a re-engagement offer across email and/or LinkedIn. You don’t need a perfect database to begin and to benefit from this approach. 

Yes, particularly for SMEs with:
  • Small commercial teams
  • Small but valuable databases
  • Long, buying cycles requiring specialist knowledge

In many cases, unlocking existing audience value is more cost-effective than scaling paid acquisition.

Qincade- Life Sciences & Biotech Marketing Agency | Cambridge & St Andrews

Hi! Let us know how we can help and we’ll respond shortly.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

auto popup img

Instant access to articles, tools & templates

Sign up to our list and be first to receive newly-published Qincade resources for science marketers.